Stephen Kelly

Stephen Kelly

Auto-generated profile, based on publicly available information

Stephen Kelly

Neuroscience Institute @JFK Medical Center, Edison, NJ, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SKS. Kelly
S. Kelly
TBT. M. Bliss
T. M. Bliss
ASA. K. Shah
A. K. Shah
GSG. H. Sun
G. H. Sun
MMM. Ma
M. Ma
GSG. K. Steinberg
G. K. Steinberg
We characterize the survival, migration, and differentiation of human neurospheres derived from CNS stem cells transplanted into the ischemic cortex of rats 7 days after distal middle cerebral artery occlusion. Transplanted neurospheres survived robustly in naive and ischemic brains 4 wk posttransplant. Survival was influenced by proximity of the graft to the stroke lesion and was negatively correlated with the number of IB4-positive inflammatory cells. Targeted migration of the human cells was seen in ischemic animals, with many human cells migrating long distances (≈1.2 mm) predominantly toward the lesion; in naive rats, cells migrated radially from the injection site in smaller number and over shorter distances (0.2 mm). The majority of migrating cells in ischemic rats had a neuronal phenotype. Migrating cells between the graft and the lesion expressed the neuroblast marker doublecortin, whereas human cells at the lesion border expressed the immature neuronal marker β-tubulin, although a small percentage of cells at the lesion border also expressed glial fibrillary acid protein (GFAP). Thus, transplanted human CNS (hCNS)-derived neurospheres survived robustly in naive and ischemic brains, and the microenvironment influenced their migration and fate.

2 April 2018 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
SHSimon J. Hawkins
Simon J. Hawkins
LCLucy A. Crompton
Lucy A. Crompton
ASAman Sood
Aman Sood
MSMargaret Saunders
Margaret Saunders
NBNoreen T. Boyle
Noreen T. Boyle
MCMaeve Caldwell
Maeve Caldwell

1 June 2007 in Molecular Therapy
Verified
Journal Article
Open access
JHJl Howarth
Jl Howarth
SKS Kelly
S Kelly
MKMp Keasey
Mp Keasey
CGCpj Glover
Cpj Glover
YLY-B Lee
Y-B Lee
JUJb Uney
Jb Uney
We studied the ability of heat shock, DnaJ-like-1 (HSJ1) proteins (which contain DnaJ and ubiquitin-interacting motifs) to reduce polyglutamine-mediated inclusion formation. The experiments demonstrated that expression of heat shock protein 70 (hsp70), hsp40, HSJ1a, and HSJ1b significantly reduced protein inclusion formation in a model of spinal and bulbar muscular atrophy (SBMA). HSJ1a also mediated a significant decrease in the number of inclusions formed in a primary neuronal model of protein aggregation. Studies to elucidate the mechanisms underlying these reductions showed that hsp70 and hsp40 increased chaperone-mediated refolding. In contrast, expression of HSJ1 proteins did not promote chaperone activity but caused an increase in ubiquitylation. Furthermore, HSJ1a was associated with a ubiquitylated luciferase complex, and in the presence of HSJ1a but not an HSJ1a UIM mutant (HSJ1a-ΔUIM) there was a reduction in luciferase protein levels. Together these results show that HSJ1 proteins mediated an increase in target protein degradation via the ubiquitin-proteasome system (UPS). We also found that the expression of HSJ1a significantly decreased the number of neurons containing inclusions in an in vivo model of polyglutamine disease. These findings indicate that targeted modification of the UPS to facilitate degradation of misfolded proteins may represent a highly effective therapeutic avenue for the treatment of polyglutamine disease.

23 July 2002 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
SKStephen Kelly
Stephen Kelly
ZZZhijian J. Zhang
Zhijian J. Zhang
HZHeng Zhao
Heng Zhao
LXLijun Xu
Lijun Xu
RGRona G. Giffard
Rona G. Giffard
GSGary K. Steinberg
Gary K. Steinberg

1 May 2003 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
HHHyung Soo Han
Hyung Soo Han
MKMurat Karabiyikoglu
Murat Karabiyikoglu
SKStephen Kelly
Stephen Kelly
RSRaymond A. Sobel
Raymond A. Sobel
MYMidori A. Yenari
Midori A. Yenari
Nuclear factor-κB (NFκB) is a transcription factor that is activated after cerebral ischemia. NFκB activation leads to the expression of many inflammatory genes involved in the pathogenesis of stroke. The authors previously showed that mild hypothermia is protective even when cooling begins 2 h after stroke onset. In the present study, they examined the influence of hypothermia on NFκB activation. Rats underwent 2 h of transient middle cerebral artery occlusion. Brains were cooled to 33°C immediately after or 2 h after occlusion, and maintained for 2 h. After normothermic ischemia (brain temperature at 38°C), NFκB cytoplasmic expression, nuclear translocation, and binding activity were observed as early as 2 h in the ischemic hemisphere and persisted at 24 h. Hypothermia decreased NFκB translocation and binding activity but did not alter overall expression. Hypothermia also affected the levels of NFκB regulatory proteins by suppressing phosphorylation of NFκB's inhibitory protein (IκB-α) and IκB kinase (IKK-γ) and decreasing IKK activity, but did not alter overall IKK levels. Hypothermia suppressed the expression of two NFκB target genes: inducible nitric oxide synthase and TNF-α. These data suggest that the protective effect of hypothermia on cerebral injury is, in part, related to NFκB inhibition due to decreased activity of IKK.

1 August 2004 in Experimental Neurology
Verified
Journal Article
Closed access
SKStephen Kelly
Stephen Kelly
HZHeng Zhao
Heng Zhao
GSGuo Hua Sun
Guo Hua Sun
DCDanye Cheng
Danye Cheng
YQYanli Qiao
Yanli Qiao
MYMidori A. Yenari
Midori A. Yenari